Yaral Pharma
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8 Campus Dr Ste 201A, Parsippany, New Je...Phone Number
(866) 218-9009Website
www.yaral-pharma.comRevenue
<$5 MillionIndustry
About Yaral Pharma
YARAL Pharma Inc. is a U.S. subsidiary of the global pharmaceutical company IBSA, dedicated to expanding access to high-quality, affordable authorized generics and complex generic medicines. The company focuses on innovative solutions that enhance healthcare outcomes while maintaining exceptional customer service. YARALDirect is a key initiative aimed at improving patient access to their generic medicines. With a patient-centered approach, YARAL Pharma emphasizes the importance of quality and innovation in its therapeutic offerings.Explore more
Yaral Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Yaral Pharma
Compare insights from companies similar to Yaral Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Yaral Pharma Tech Stack
A closer look at the technologies used by Yaral Pharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Yaral Pharma
Sign Up For FreeTo access detailed company insights
YARAL Pharma Inc. is a U.S. subsidiary of the global pharmaceutical company IBSA, dedicated to expanding access to high-quality, affordable authorized generics and complex generic medicines. The company focuses on innovative solutions that enhance healthcare outcomes while maintaining exceptional customer service. YARALDirect is a key initiative ai... Read More
